Literature DB >> 17050204

Immune-mediated myelopathy following allogeneic stem cell transplantation.

Miwa Sakai1, Kazuteru Ohashi, Keiko Ohta, Takuya Yamashita, Hideki Akiyama, Shuji Kisida, Noriko Kamata, Hisashi Sakamaki.   

Abstract

We report a case of immune-mediated myelopathy occurring 4 months after unrelated bone marrow transplantation for myelodysplastic syndrome. After the tapering of cyclosporine for graft-versus-host disease prophylaxis, the patient developed several neurological symptoms mimicking the clinical features of multiple sclerosis (MS). Although neurological exacerbation was well stabilized with a bulk dose of corticosteroid, sustained improvement of neurological deficits occurred after the patient developed hematopoietic mixed chimerism (HMC). This experience may provide clinical evidence supporting the current therapeutic concept, in which HMC induction can potentially cure several immune diseases, including MS.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17050204     DOI： 10.1532/IJH97.06060

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  15 in total

1.  Calcineurin-inhibitor pain syndrome following haematopoietic stem cell transplantation.

Authors:  Aiko Kida; Kazuteru Ohashi; Chikako Tanaka; Noriko Kamata; Hideki Akiyama; Hisashi Sakamaki
Journal:  Br J Haematol       Date:  2004-08       Impact factor: 6.998

2.  Prospective evaluation of neurological complications after allogeneic bone marrow transplantation.

Authors:  P Sostak; C S Padovan; T A Yousry; G Ledderose; H-J Kolb; A Straube
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

Review 3.  Treatment of severe autoimmune disease by stem-cell transplantation.

Authors:  Megan Sykes; Boris Nikolic
Journal:  Nature       Date:  2005-06-02       Impact factor: 49.962

4.  Central and peripheral nervous system complications following allogeneic bone marrow transplantation.

Authors:  C Solaro; A Murialdo; D Giunti; G Mancardi; A Uccelli
Journal:  Eur J Neurol       Date:  2001-01       Impact factor: 6.089

Review 5.  Neurological complications of hematopoietic cell transplantation.

Authors:  Albert Saiz; Francesc Graus
Journal:  Semin Neurol       Date:  2004-12       Impact factor: 3.420

6.  [A case of inflammatory demyelinative myelopathy after bone marrow transplantation].

Authors:  N Saito; T Tanaka; S Matsuda; M Inoue; T Yamamoto
Journal:  Rinsho Shinkeigaku       Date:  2000-06

7.  [A case of asymmetric demyelinating neuropathy in a patient with chronic graft-versus-host disease].

Authors:  Hideyuki Matsumoto; Naoko Seki; Tomotaka Yamamoto; Kumi Oshima; Takashi Asai; Toru Motokura; Yoshikazu Ugawa; Jun Goto; Shoji Tsuji
Journal:  Rinsho Shinkeigaku       Date:  2005-10

8.  Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

Authors:  Frédéric Baron; Jennifer E Baker; Rainer Storb; Theodore A Gooley; Brenda M Sandmaier; Michael B Maris; David G Maloney; Shelly Heimfeld; Dmitrij Oparin; Eustacia Zellmer; Jerald P Radich; F Carl Grumet; Karl G Blume; Thomas R Chauncey; Marie-Térèse Little
Journal:  Blood       Date:  2004-06-29       Impact factor: 22.113

9.  Graft-versus-host disease in the central nervous system. A real entity?

Authors:  E Rouah; R Gruber; W Shearer; D Armstrong; E P Hawkins
Journal:  Am J Clin Pathol       Date:  1988-04       Impact factor: 2.493

Review 10.  Immunological importance of chimerism in transplantation: new conditioning protocol in BMT and the development of chimeric state.

Authors:  A Barta; A Bátai; E Kelemen; L Lengyel; P Reményi; A Sipos; E Torbágyi; M Avalos; E Fekete; J Földi; P Páldi-Haris; J Tamáska; E Gyódi; K Rajczy; I Hoffer; J Jakab; G G Petrányi; K Pálóczi
Journal:  Hum Immunol       Date:  2000-02       Impact factor: 2.850
View more
  7 in total

1.  A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation.

Authors:  Gi-June Min; Silvia Park; Sung-Soo Park; Jae-Ho Yoon; Sung-Eun Lee; Byung-Sik Cho; Ki-Seong Eom; Seok Lee; Hee-Je Kim; Chang-Ki Min; Seok-Goo Cho; Dong-Wook Kim; Jong-Wook Lee; Yoo-Jin Kim
Journal:  Int J Hematol       Date:  2019-07-15       Impact factor: 2.490

2.  Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease.

Authors:  Anna Maria Delios; Marc Rosenblum; Ann A Jakubowski; Lisa M DeAngelis
Journal:  J Neurooncol       Date:  2012-08-23       Impact factor: 4.130

3.  Neurological complications of transplantation: part I: hematopoietic cell transplantation.

Authors:  Amy A Pruitt; Francesc Graus; Myrna R Rosenfeld
Journal:  Neurohospitalist       Date:  2013-01

4.  Autoimmune Demyelinating Polyneuropathy as a Manifestation of Chronic Graft-versus-Host Disease after Adult Cord Blood Transplantation in a Patient with Chronic Lymphocytic Leukemia.

Authors:  Fredrick Hogan; Melhem Solh
Journal:  Case Rep Hematol       Date:  2014-09-14

5.  A Case of Multiple Sclerosis-Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature.

Authors:  Joyutpal Das; Atta Gill; Christine Lo; Natalie Chan-Lam; Siân Price; Stephen B Wharton; Helen Jessop; Basil Sharrack; John A Snowden
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

6.  Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells.

Authors:  Behnam Sadeghi; Bo Ersmark; Gianluca Moretti; Jonas Mattsson; Olle Ringdén
Journal:  Int J Hematol       Date:  2019-12-18       Impact factor: 2.490

Review 7.  Stem Cell Therapy in Neuroimmunological Diseases and Its Potential Neuroimmunological Complications.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Lea Grote-Levi; Nora Möhn; Kurt-Wolfram Sühs; Britta Eiz-Vesper; Britta Maecker-Kolhoff; Corinna Trebst; Thomas Skripuletz; Martin W Hümmert
Journal:  Cells       Date:  2022-07-11       Impact factor: 7.666
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.